|

Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment

RECRUITINGSponsored by Assistance Publique - Hôpitaux de Paris
Actively Recruiting
SponsorAssistance Publique - Hôpitaux de Paris
Started2022-01-23
Est. completion2041-05-01
Eligibility
Age15 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04844151

Summary

The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.

Eligibility

Age: 15 Years+Healthy volunteers accepted
Inclusion Criteria:

* Acute myocarditis confirmed by cardiac magnetic resonance according to Lake Louise modified criteria or by endomyocardial biopsy according to histologic, immunologic and immunohistochemic criteria.
* affiliation to the French Health Care System "Sécurité sociale"

Exclusion Criteria:

* Severe valvulopathy
* Complex congenital cardiopathy
* Previous heart transplant
* Known significative coronary disease

Conditions2

Heart DiseaseMyocarditis

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.